The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
U.S. regulators plan an extensive study of blood-pressure drugs that generate almost 40 million prescriptions a year, after receiving thousands of complaints from doctors and patients.
Cigna Corp. fell the most in two years after the health insurer said first-quarter earnings probably will decline and provided a full-year forecast lower than analysts expected.